Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Carcinoma, Medullary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07812779
What this trial is testing

Thyroid Health Outcomes Registry for Surgery

Who this might be right for
Thyroid DiseasesThyroid NeoplasmsThyroid Cancer+9 more
Pirogov Russian National Research Medical University 3,000
Not applicableNot Yet RecruitingNCT07048964
What this trial is testing

A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations

Who this might be right for
Medullary Thyroid Cancer (MTC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT00625846
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer

Who this might be right for
Recurrent Thyroid Gland CarcinomaStage III Differentiated Thyroid Gland Carcinoma AJCC v7Stage III Thyroid Gland Medullary Carcinoma AJCC v7+10 more
National Cancer Institute (NCI) 152
Not applicableNot Yet RecruitingNCT07621146
What this trial is testing

A Comparison of [68Ga]DOTATATE and [18F]AmBF3TATE for the Staging and Assessment of Neuroendocrine Malignancies

Who this might be right for
Neuroendocrine Tumors, NETPheochromocytoma/ParagangliomaSSTR-expressing Tumors+1 more
British Columbia Cancer Agency 51
Testing effectiveness (Phase 2)Study completedNCT00869050
What this trial is testing

Capecitabine and Temozolomide for Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Tumors
Columbia University 41
Not applicableStudy completedNCT02856347
What this trial is testing

Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin

Who this might be right for
Medullary Thyroid Cancer
Institut Claudius Regaud 24
Not applicableApproved For MarketingNCT03906331
What this trial is testing

Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation

Who this might be right for
Non Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+4 more
Eli Lilly and Company
Not applicableNo Longer AvailableNCT02174679
What this trial is testing

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

Who this might be right for
Carcinoid CancerNeuroendocrine TumorsMedullary Thyroid Cancer+1 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Early research (Phase 1)Not Yet RecruitingNCT07661420
What this trial is testing

211At-MABG in Adults With Advanced Neuroendocrine Cancers

Who this might be right for
PheochromocytomaParagangliomaNeuroendocrine Tumors+3 more
University of Pennsylvania 16
Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Not applicableLooking for participantsNCT07142005
What this trial is testing

Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer (MTC)Cultural Adaptation
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06121271
What this trial is testing

Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed Indications

Who this might be right for
Bronchial and Thymic Neuroendocrine TumourParaganglioma/ PhaeochromocytomaMedullary Thyroid Carcinoma+1 more
University College, London 110
Not applicableLooking for participantsNCT06141369
What this trial is testing

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Who this might be right for
Adrenal Cortical CarcinomaMedullary Thyroid CancerThymic Neuroendocrine Carcinoma+1 more
Shanghai Jiao Tong University School of Medicine 21
Testing effectiveness (Phase 2)Study completedNCT02614495
What this trial is testing

Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma

Who this might be right for
Thyroid Carcinoma
Hutchison Medipharma Limited 66
Not applicableUnknownNCT00687778
What this trial is testing

11C-Acetate PET/CT Non-FDG-Avid Tumors

Who this might be right for
Soft Tissue SarcomasThyroid CancerLung Cancer+7 more
Tel-Aviv Sourasky Medical Center 100
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Early research (Phase 1)Study completedNCT03780517
What this trial is testing

Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors

Who this might be right for
Advanced Nonhaematologic Malignancies
Boston Pharmaceuticals 117
Post-approval studies (Phase 4)Active Not RecruitingNCT01896479
What this trial is testing

Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer
Exelixis 247
Next Page